GlassScriptPhysician profile
Dale G Leffler
NPI 1346463254
$19,784.54
in general payments reported to CMS, 2019-2025
40 companies · $3,158 in 2025
The $3,158 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,116 · 2020: $645 · 2021: $634 · 2022: $6,012 · 2023: $1,754 · 2024: $3,465 · 2025: $3,158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,233 · Travel and Lodging: $3,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,233.37 |
| Travel and Lodging | $3,143.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,971.59 | 2019-2025 | Perclose Proglide, Supera, Optis |
| Medtronic, INC. | $3,391.43 | 2021-2025 | Corevalve Evolut R, Micra, Linq II |
| Medtronic Vascular, INC. | $2,565.94 | 2019-2020 | |
| Boston Scientific Corporation | $1,438.61 | 2019-2024 | Watchman Access System, Ranger, Eluvia |
| Penumbra, INC. | $1,406.96 | 2025 | Indigo System |
| Biosense Webster, INC. | $500.80 | 2022-2025 | Carto 3, Nuvision Ice Catheter |
| Shockwave Medical, INC | $469.02 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $360.39 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $352.59 | 2019-2025 | |
| Amgen INC. | $260.76 | 2020-2024 | Repatha |
| Philips North America LLC | $197.98 | 2022-2024 | (Az7) Lasers |
| E.R. Squibb & Sons, L.L.C. | $183.74 | 2022-2024 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.81 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $152.33 | 2019-2024 | Wainua, Brilinta |
| Terumo Medical Corporation | $145.77 | 2024-2025 | Azur Cx Detachable, Metacross Otw, Glidewire |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Leffler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.